MHLW Panel OKs Celgene’s Apremilast, 2 Other NMEs

November 25, 2016
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) recommended approval for three new molecular entities (NMEs) including Celgene’s apremilast on November 24. The Pharmaceutical Affairs and Food Sanitation Council’s Second Committee on Drugs, a de-facto...read more